These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10833076)

  • 21. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of placebo in a trial of thalidomide for pediatric Crohn disease.
    El-Matary W
    JAMA; 2014 Mar; 311(12):1251. PubMed ID: 24668111
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of placebo in a trial of thalidomide for pediatric Crohn disease--reply.
    Lazzerini M; Martelossi S; Ventura A
    JAMA; 2014 Mar; 311(12):1251-2. PubMed ID: 24668112
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
    Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
    White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
    Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of thalidomide therapy in pediatric Crohn's disease with evidence of tuberculosis.
    Wang L; Hong Y; Wu J; Leung YK; Huang Y
    World J Gastroenterol; 2017 Nov; 23(43):7727-7734. PubMed ID: 29209113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G; Herfarth H
    Dtsch Med Wochenschr; 2002 May; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract]   [Full Text] [Related]  

  • 30. Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Bousvaros A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1750-1. PubMed ID: 26199988
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Lazzerini M; Martelossi S; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1752-3. PubMed ID: 25993695
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.
    Lazzerini M; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Lorusso M; Mangiantini F; Fontana M; Zuin G; Palla G; Maggiore G; Bramuzzo M; Pellegrin MC; Maschio M; Villanacci V; Manenti S; Decorti G; De Iudicibus S; Paparazzo R; Montico M; Ventura A
    JAMA; 2013 Nov; 310(20):2164-73. PubMed ID: 24281461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac amyloidosis--sustained clinical and free light chain response to low dose thalidomide and corticosteroids.
    Campbell P; Murdock C
    Intern Med J; 2006 Feb; 36(2):137-9. PubMed ID: 16472271
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease.
    Simon M; Pariente B; Lambert J; Cosnes J; Bouhnik Y; Marteau P; Allez M; Colombel JF; Gornet JM
    Clin Gastroenterol Hepatol; 2016 Jul; 14(7):966-972.e2. PubMed ID: 26598226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil for Crohn's disease?
    Lowry PW; Sandborn WJ; Lipsky JJ
    Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
    [No Abstract]   [Full Text] [Related]  

  • 36. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
    Plamondon S; Ng SC; Kamm MA
    Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate dose in current ECCO consensus on Crohn's disease.
    Karaca C
    J Crohns Colitis; 2010 Oct; 4(4):483. PubMed ID: 21122548
    [No Abstract]   [Full Text] [Related]  

  • 38. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
    Bauditz J; Wedel S; Lochs H
    Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results.
    Lazzerini M; Martelossi S; Marchetti F; Scabar A; Bradaschia F; Ronfani L; Ventura A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):419-27. PubMed ID: 17269997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
    van den Brande JM; Peppelenbosch MP; Hommes DW
    Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.